Breast Cancer HER2 Test For Herceptin Candidates Approved By FDA

[News]

The US Food and Drug Administration (FDA) announced on Tuesday that it had approved a new test that measures the strength of HER2 gene amplification in breast cancer patients so that decisions can be made about whether they should be given the cancer drug Herceptin (trastuzumab).

More... (http://www.medicalnewstoday.com/articles/114372.php)